Please login to the form below
NICE
This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.
Abivax’s COVID-19 study declared Research National Priority by French government
The study, which is being conducted at the University Hospital Center in Nice, France, is investigating the effect of early treatment with ABX464 in 1, 034 elderly or high-risk patients
Latest news
-
UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme
National Institute for Health and Care Excellence (NICE) and NHS England and Improvement (NHSE&I).
-
Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer
Securing NHS reimbursement is the culmination of collaborative discussions that we have been having with NICE and NHS England since the end of last year,” said Laura McMullin, general manager UK ... We worked closely with clinicians to submit evidence
-
MSD launches antibiotic combo Recarbrio in UK
The new subscription trial, led by the UK National Institute for Health and Care Excellence (NICE) and NHS England and Improvement will see pharmaceutical companies paid upfront for access to drugs
-
NICE launches consultation on its methods of drug evaluation
In addition, new cancer treatments can be approved via NICE’s Cancer Drugs Fund (CDF) which was introduced in 2016. ... NICE said there is also a ‘case for change’ regarding how it values costs and health effects for health technologies.
-
Novartis’ MS therapy Mayzent approved by NICE
According to NICE, around 11, 000 people with SPMS will now be eligible to receive Mayzent treatment. ... unmet clinical need,” said Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation at NICE.
More from news
Approximately 393 fully matching, plus 831 partially matching documents found.
Latest Intelligence
-
Can digital communications boost behaviour change?
Digital health interventions. New NICE guidelines, published in October 2020, highlight goal planning, monitoring and social support as the components to focus on when developing digital health interventions.
-
Power to the patient: digital innovation supporting patients with chronic diseases
An example of a company working hard to put this into practice and making digital innovation and evaluation a ‘must’, and not a ‘nice to have’, is AbbVie, which has, with
-
NICE – but not enough
Today – more than three years after its NICE TA – Olumiant is finally approaching full implementation. ... Armed with positive NICE guidance, MSD did a great job of getting Steglatro on formulary.
-
How COVID-19 is accelerating the threat of antimicrobial resistance
Trisha Greenlagh, an internationally recognised primary care professor, posted on Twitter in early April pointing out the NICE guidelines about the use of antibiotics for mild COVID pneumonia.
-
How to create real, lasting change after COVID-19
The choice of picking up a phone, meeting in person or joining the discussion online is no longer a ‘nice to have’ but a basic necessity.
More from intelligence
Approximately 12 fully matching, plus 122 partially matching documents found.
Latest appointments
-
NICE looks internally for new chief executive
He was appointed in April 1999 when NICE was first established under Tony Blair’s ‘New Labour’ government. ... I am delighted that Gill has been appointed as NICE’s next chief executive.
-
Professor Carole Longson moves from NICE to the ABPI
The Association of the British Pharmaceutical Industry (ABPI) has attracted Professor Carole Longson away from the National Institute for Health and Care Excellence (NICE) to be its new chief scientific officer, ... She most recently spent the 18 years
-
New health ministers and re-appointments after reshuffle
Freeman's role is also tied into the Department for Business, Innovation and Skills and includes expanded responsibility for the Cancer Drugs Fund, NICE and MHRA, research and development, issues around
-
Virgo Health Education appoints new senior team
She has over 15 years' experience working in medical education and is a member of the ISMPP Ethics Committee, the NICE Implementation External Reference Group and part of the Royal Berkshire
-
Former NICE chair Sir Michael Rawlins to lead MHRA
Care Excellence (NICE) from its formation in 1999 to his departure last year.
More from appointments
Approximately 4 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
Aurora celebrates 15 years of improving lives
It has:. Turned around NICE decisions. Added products to guidelines. Successfully launched a number of healthcare “firsts”, including the first pill in multiple sclerosis and the first genetic modifier in cystic
-
Let's be ambitious for patients and life sciences investment in Global Britain
One argument against NICE reform is its potential greater impact on NHS budgets. ... A new 10-year VPAS with more substantial and defined NICE reform locked in?
-
The impact of COVID-19 on cancer care
Current NICE guidance states that face-to-face contact should continue to be minimised by opting for telephone or video consultations, postponing non-essential follow-up appointments, using home delivery of ... NICE has also issued guidance for
-
The Patient as Priority: How can effective internal training contribute to improving patient outcomes?
Distinguish between need to know, useful to know and nice to know content.
-
A day in the life of Becca McConnell a Senior Account Executive
It’s also nice to have real responsibility and feel like I am an important member of the team.
More from PMHub
Approximately 2 fully matching, plus 49 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- COVID-19 vaccine developers respond to new strain
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- bluebird bio to separate oncology and rare diseases units
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
